Deepull: Didier Deltort

Didier Deltort has been appointed to the board of directors of Spanish molecular diagnostics developer Deepull. Deltort is a senior advisor at Mérieux Equity Partners, and will be the board representative of the Pertinence Invest 2 Fund managed by UI Investissement and advised by Mérieux Equity Partners. Previously he held senior roles in Europe, the Middle East, and the US for GE Healthcare, including senior VP of global monitoring solutions and managing director of GE Healthcare Finland. He has also previously held leadership roles at Boston Scientific, Zimmer Biomet, and HP. He holds a master's degree in biomedical engineering from the Université de Technologie de Compiègn in France.